GPX4 and neoplasm: Additionally, USP24 knockdown enhanced the anti-tumor effects of other GPX4 inhibitors, including ML162, ML210, and FIN56, in MDA-MB-231 cells, while exerting minimal impact on erastin-induced ferroptosis (Fig. 2D).